211 related articles for article (PubMed ID: 7511020)
1. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus.
Meijer C; Huysen V; Smeenk RT; Swaak AJ
Lupus; 1993 Dec; 2(6):359-65. PubMed ID: 7511020
[TBL] [Abstract][Full Text] [Related]
2. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
4. Observations on the interleukin-6 and acute phase protein profiles in the disease course of patients with lupus erythematosus.
Swaak AJ; Sintnicolaas C; Meijer C; Smeenk RT
Lupus; 1992 May; 1(3):151-5. PubMed ID: 1284544
[TBL] [Abstract][Full Text] [Related]
5. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus.
Swaak AJ; van Rooyen A; Aarden LA
Rheumatol Int; 1989; 8(6):263-8. PubMed ID: 2471249
[TBL] [Abstract][Full Text] [Related]
8. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
Liou LB
Clin Exp Rheumatol; 2001; 19(5):515-23. PubMed ID: 11579710
[TBL] [Abstract][Full Text] [Related]
9. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response.
Stam TC; Swaak AJ; Kruit WH; Stoter G; Eggermont AM
Eur J Clin Invest; 2000 Apr; 30(4):336-43. PubMed ID: 10759883
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
Czelej D; Chodorowska G; Lechowska-Mazur I
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus.
Studnicka-Benke A; Steiner G; Petera P; Smolen JS
Br J Rheumatol; 1996 Nov; 35(11):1067-74. PubMed ID: 8948291
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
Chodorowska G; Czelej D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
[TBL] [Abstract][Full Text] [Related]
14. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
[TBL] [Abstract][Full Text] [Related]
15. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
[TBL] [Abstract][Full Text] [Related]
16. The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.
da Silva AE; dos Reis-Neto ET; da Silva NP; Sato EI
Lupus; 2013 Dec; 22(14):1479-83. PubMed ID: 24135080
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.
Brink I; Thiele B; Burmester GR; Trebeljahr G; Emmrich F; Hiepe F
Lupus; 1999; 8(9):723-30. PubMed ID: 10602444
[TBL] [Abstract][Full Text] [Related]
18. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Pochopień-Kenig G; Scieszka J
Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
[TBL] [Abstract][Full Text] [Related]
19. Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs.
Yamashita K; Fujinaga T; Miyamoto T; Hagio M; Izumisawa Y; Kotani T
J Vet Med Sci; 1994 Jun; 56(3):487-92. PubMed ID: 7524694
[TBL] [Abstract][Full Text] [Related]
20. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
